ELN and Hepatic fibrosis: The feasibility of monitoring ECMs with ESMA (Figure 6), the elastin-specific MR contrast agent, has previously been assessed, and the study findings suggested that elastin-based molecular MRI has potential as a noninvasive method for monitoring ECM remodeling during liver fibrosis [43].